Isolation of SARS-CoV-2 N501Y mutation?

Medicines and Healthcare Products Regulatory Agency did not have the information requested.

Dominique Anderson

Dear Medicines and Healthcare products Regulatory Agency,

I am requesting an accurate and complete list of records held by the Medicines and Healthcare products Regulatory Agency describing the isolation of SARS-CoV-2 N501Y mutation?
Taken directly from an asymptomatic patient with SARS-CoV-2 N501Y mutation?

Yours faithfully,

Dominique Anderson

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

Dominique Anderson

Dear Medicines and Healthcare products Regulatory Agency,

I look forward to you fulfilling my FOI request.

Yours faithfully,

Dominique Anderson